FDA Appeal In Zocor Case Could Open The Door For More Generics In The Fall
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA filed a notice of appeal challenging a court decision granting Ivax and Ranbaxy 180-day exclusivity for generic simvastatin.